4Yashima Y, Ohgane T. Pharmacological profiles of mycophenolate mofetil, a new immuosuppressive agent [ J ]. Nippon Yakurigaku Zasshi,2001,117(2) :131.
5Allison AC ,Eugui EM. Mycophenolate mofetil and its mechanisms of action [ J ]. Immunopharmacology,2000,47 (2-3) :85.
6Coma D, Marina M, Facchinetti D, et al. Mycophenolate mofetil limits renal damage and prolongs life in murin lupus autoimmune disease[J]. Kindey Int,1997,51:1583.
7Alison AC, KowalskiWJ, Muller CT, et al. Mycophenolic acid and breguiher,inhibitor of puine and pyrimde synthesis, blok the glycosylation of adhesion moleculcs [ J ]. Transplant Proceed, 1993,25 (S2) :67.
8Hauser IA, Rebders L, Radeke HH, et al. Mycophenolate mofetil inhibits rat and human mesangial cell prolifeation by guanosine depletion[J]. Nephrol Dial Transplant,1999,14( 1 ) :58-63.
10Durez P, Appelboom T, Pira C, et al. Antiinflammatory properties of mycophenolate mofetil in murine endotoxemia:inhibition of TNFalpha and upregulation of IL-10 release [ J ]. Int J Immunopharmacol, 1999,21:58.
